Related Experiment Video
Updated: Apr 12, 2026

09:06
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
898
Mesenchymal stromal cells and the acute respiratory distress syndrome (ARDS): challenges for clinical application
J E Millar1, J F Fraser2, D F McAuley3
1Department of Anaesthesia, Critical Care & Pain, University of Glasgow, Glasgow, UK.
Thorax
|May 21, 2015
Abstract
No abstract available in PubMed .
Related Concept Videos
Mesenchymal Stem Cells
6.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K
Acute Respiratory Failure-II
1.6K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K

